Literature DB >> 22550308

Occupational radiation dose: percutaneous interventional procedures on hemodialysis arteriovenous fistulas and grafts.

Sam Heye1, Geert Maleux, Raymond H Oyen, Kathleen Claes, Dirk R J Kuypers.   

Abstract

PURPOSE: To evaluate operator radiation exposure during percutaneous interventions on hemodialysis arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs).
MATERIALS AND METHODS: Seventy-seven procedures were performed in 57 patients while the interventional radiologist wore two ring dosimeters, two thermoluminescent dosimeters at the lower legs, and a thermoluminescent dosimeter on the forehead. Dose-area product, fluoroscopy time, total procedure time, and radiation exposures to eye lens, hands, and legs were recorded. Variables were procedure type, access site side, and angiography equipment. Statistical analysis was performed with the signed-rank and Mann-Whitney U tests.
RESULTS: Mean operator radiation doses for the left hand, right hand, eye lens, left leg, and right leg were 0.28, 0.28, 0.03, 0.11, and 0.12 mSv, respectively. Radiation exposure to the hands was significantly higher compared with that to the legs (P<.0001). In recanalization procedures, fluoroscopy time, total procedure time, and mean number of angiographic runs were higher (all P<.001) than those for percutaneous transluminal angioplasty (PTA), as were radiation exposures to the hands and left leg (all P<.05). Left-sided access interventions resulted in higher doses to the right hand and leg (both P<.05). For right-sided access interventions, doses to the left hand and leg were higher (P<.0001). Eye lens radiation dose was significantly higher for procedures with the flat-panel detector system (P=.002).
CONCLUSION: Operator radiation exposure to the hands, legs, and eyes during percutaneous interventional procedures performed on hemodialysis AVFs and AVGs is relatively low. Radiation exposure to the hands was higher than that to the legs, and the hand and leg closest to the AVF or AVG received a higher dose. Recanalization procedures resulted in higher doses to the hands and left leg than did PTA. Eye lens radiation dose may be higher with a flat-panel detector system. © RSNA, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 22550308     DOI: 10.1148/radiol.12110978

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

Review 1.  Physician and Patient Radiation Exposure During Endovascular Procedures.

Authors:  Andrew M Goldsweig; J Dawn Abbott; Herbert D Aronow
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

Review 2.  Role of interventional nephrology in the multidisciplinary approach to hemodialysis vascular access care.

Authors:  Gerald A Beathard
Journal:  Kidney Res Clin Pract       Date:  2015-07-26

3.  Impact of Allura Clarity Technology on Radiation Dose Exposure During Left Atrial Appendage Closure.

Authors:  Emilia Studzińska; Maria Anna Staniszewska
Journal:  Pol J Radiol       Date:  2017-10-20

4.  Fistuloplasty using a radiation-and-time-saving sheathless balloon catheter.

Authors:  Joel Crawford; Angela Kokkosis; Pamela Kim; Antonios Gasparis; Nicos Labropoulos
Journal:  J Vasc Access       Date:  2018-10-14       Impact factor: 2.283

5.  Evaluation of skeletal muscle microvascular perfusion of lower extremities by cardiovascular magnetic resonance arterial spin labeling, blood oxygenation level-dependent, and intravoxel incoherent motion techniques.

Authors:  Shiteng Suo; Lan Zhang; Hui Tang; Qihong Ni; Suqin Li; Haimin Mao; Xiangyu Liu; Shengyun He; Jianxun Qu; Qing Lu; Jianrong Xu
Journal:  J Cardiovasc Magn Reson       Date:  2018-03-19       Impact factor: 5.364

6.  Imaging of Patients with Complex Hemodialysis Arterio-Venous Fistulas using Time-Resolved Dynamic CT Angiography: Comparison with Duplex Ultrasound.

Authors:  Mathias Meyer; Nicole Geiger; Urs Benck; Daniela Rose; Sonja Sudarski; Melissa M Ong; Stefan O Schoenberg; Thomas Henzler
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.